<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03577964</url>
  </required_header>
  <id_info>
    <org_study_id>267/17</org_study_id>
    <nct_id>NCT03577964</nct_id>
  </id_info>
  <brief_title>Development of Pneumonia Due to Alveolar Glucose Levels in Systemic Hyperglycemia</brief_title>
  <official_title>Development of Pneumonia Due to Alveolar Glucose Levels in Systemic Hyperglycemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Ulm</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Ulm</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Incidence of Pneumonia in Patients with high systemic glucose levels.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Clinical and mechanistic studies have shown that a hyperglycaemic metabolic condition is
      associated with a higher incidence of infection and consecutive increased morbidity and
      mortality. The underlying mechanisms in detail are not completely understood. So far it is
      not clear whether systemic increased glucose levels are caused by a stress reaction of the
      body through a catabolic metabolism situation as well as a &quot;stress-induced insulin
      resistance&quot;, or infections are promoted by hyperglycemia. From in vivo and in vitro studies,
      a glucose threshold for the lung is known (147 mg / dL), similar to that in the kidney. It
      can be hypothesized, that an intra-alveolar glucose in turn promotes bacterial growth as a
      nutrient substrate. The aim of the study is to determine the concentration of glucose in the
      alveolar space in connection with hyperglycemic conditions, and to demonstrate a higher
      incidence of pneumonia in this patient group. The study will enroll cardiac surgery patients
      receiving surgical treatment and expected postoperative ventilation. Systemic blood glucose
      monitoring is recorded throughout hospitalization, as well as the removal of bronchial
      aspirates intraoperatively and during ventilation to measure glucose levels and bacterial
      levels. The incidence of pneumonia is recorded during the postoperative period by means of
      radiological examinations and / or microbiological examinations.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">September 1, 2017</start_date>
  <completion_date type="Anticipated">April 25, 2020</completion_date>
  <primary_completion_date type="Actual">April 25, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of pneumonia or lower respiratory tract infection</measure>
    <time_frame>20 days post surgery</time_frame>
    <description>The incidence of pneumonia or lower respiratory tract infection will be determined by chest x-ray, CT-Scan and/or sampling of specimens of the lower tract of the airways.</description>
  </primary_outcome>
  <enrollment type="Actual">61</enrollment>
  <condition>Glucose Metabolism Disorders</condition>
  <condition>Pneumonia, Bacterial</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Glucose Measurements,</intervention_name>
    <description>Measurement of glucose Levels in bronchio alveolar secretions</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients receiving an planned cardiac surgical procedure.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women and men over the age of 18 years

          -  voluntary consent to study participation of the patient

          -  Planned cardiac surgery with expected endotracheal ventilation of ≥ 1 day
             postoperatively

        Exclusion Criteria:

          -  age &lt;18 years

          -  pregnancy

          -  Non-able-bodied patients (disempowerment / loss of consciousness, limitation of the
             ability to express one's own will, for example through disability)

          -  subsequently withdrawn consent

          -  accommodation in an institution on the basis of official or court orders

          -  lack of or insufficient knowledge of German language, whereby the understanding of the
             written patient education is not guaranteed.

          -  Immunosuppressed patients

          -  Patients with a malignant disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Kraft, MD, MMS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Ulm Dept. of Cardiothoracic and Vascular Surgery</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Ulm Dept. of Surgery</name>
      <address>
        <city>Ulm</city>
        <state>Baden Wüttemberg</state>
        <zip>89070</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Kraft R, Herndon DN, Mlcak RP, Finnerty CC, Cox RA, Williams FN, Jeschke MG. Bacterial respiratory tract infections are promoted by systemic hyperglycemia after severe burn injury in pediatric patients. Burns. 2014 May;40(3):428-35. doi: 10.1016/j.burns.2013.07.007. Epub 2013 Sep 25.</citation>
    <PMID>24074819</PMID>
  </reference>
  <reference>
    <citation>Wood DM, Brennan AL, Philips BJ, Baker EH. Effect of hyperglycaemia on glucose concentration of human nasal secretions. Clin Sci (Lond). 2004 May;106(5):527-33.</citation>
    <PMID>14678009</PMID>
  </reference>
  <reference>
    <citation>Kalsi KK, Baker EH, Fraser O, Chung YL, Mace OJ, Tarelli E, Philips BJ, Baines DL. Glucose homeostasis across human airway epithelial cell monolayers: role of diffusion, transport and metabolism. Pflugers Arch. 2009 Mar;457(5):1061-70. doi: 10.1007/s00424-008-0576-4. Epub 2008 Sep 10.</citation>
    <PMID>18781323</PMID>
  </reference>
  <reference>
    <citation>Philips BJ, Redman J, Brennan A, Wood D, Holliman R, Baines D, Baker EH. Glucose in bronchial aspirates increases the risk of respiratory MRSA in intubated patients. Thorax. 2005 Sep;60(9):761-4.</citation>
    <PMID>16135681</PMID>
  </reference>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>June 7, 2018</study_first_submitted>
  <study_first_submitted_qc>June 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 5, 2018</study_first_posted>
  <last_update_submitted>April 25, 2019</last_update_submitted>
  <last_update_submitted_qc>April 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Ulm</investigator_affiliation>
    <investigator_full_name>Robert Kraft MD, MMS</investigator_full_name>
    <investigator_title>Pricipal Investigator of Clinical Research, Dept of Cardiac, Thoracic and Vascular Surgery</investigator_title>
  </responsible_party>
  <keyword>Pneumonia</keyword>
  <keyword>Glucose</keyword>
  <keyword>Infections</keyword>
  <keyword>Respiratory Tract Infection</keyword>
  <keyword>Hyperglycemia</keyword>
  <keyword>Critical Care</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia, Bacterial</mesh_term>
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Hyperglycemia</mesh_term>
    <mesh_term>Metabolic Diseases</mesh_term>
    <mesh_term>Glucose Metabolism Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>August 1, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/64/NCT03577964/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 1, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/64/NCT03577964/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

